132 related articles for article (PubMed ID: 8007695)
1. Definition of regions of the human genome affected by loss of heterozygosity in primary human breast tumors.
Callahan R; Cropp C; Sheng ZM; Merlo G; Steeg P; Liscia D; Lidereau R
J Cell Biochem Suppl; 1993; 17G():167-72. PubMed ID: 8007695
[TBL] [Abstract][Full Text] [Related]
2. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.
Niederacher D; Picard F; van Roeyen C; An HX; Bender HG; Beckmann MW
Genes Chromosomes Cancer; 1997 Mar; 18(3):181-92. PubMed ID: 9071571
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.
Cropp CS; Lidereau R; Campbell G; Champene MH; Callahan R
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7737-41. PubMed ID: 1977164
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy.
Watatani M; Nagayama K; Imanishi Y; Kurooka K; Wada T; Inui H; Hirai K; Ozaki M; Yasutomi M
Breast Cancer Res Treat; 1993 Dec; 28(3):231-9. PubMed ID: 7912561
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
7. Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted.
Cropp CS; Champeme MH; Lidereau R; Callahan R
Cancer Res; 1993 Dec; 53(23):5617-9. PubMed ID: 8242614
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
Andersen TI; Gaustad A; Ottestad L; Farrants GW; Nesland JM; Tveit KM; Børresen AL
Genes Chromosomes Cancer; 1992 Mar; 4(2):113-21. PubMed ID: 1373310
[TBL] [Abstract][Full Text] [Related]
9. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a second tumor suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas.
Merlo GR; Venesio T; Bernardi A; Cropp CS; Diella F; Cappa AP; Callahan R; Liscia DS
Cancer Genet Cytogenet; 1994 Sep; 76(2):106-11. PubMed ID: 7923057
[TBL] [Abstract][Full Text] [Related]
11. Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors.
Nagai MA; Medeiros AC; Brentani MM; Brentani RR; Marques LA; Mazoyer S; Mulligan LM
Oncology; 1995; 52(6):448-53. PubMed ID: 7478429
[TBL] [Abstract][Full Text] [Related]
12. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
14. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases.
Rodriguez C; Vallès H; Causse A; Johannsdottir V; Eliaou JF; Theillet C
Genes Chromosomes Cancer; 2002 Feb; 33(2):141-9. PubMed ID: 11793440
[TBL] [Abstract][Full Text] [Related]
15. Genetic and molecular heterogeneity of breast cancer cells.
Callahan R; Cropp C; Merlo GR; Diella F; Venesio T; Lidereau R; Cappa AP; Lisicia DS
Clin Chim Acta; 1993 Jul; 217(1):63-73. PubMed ID: 8222284
[TBL] [Abstract][Full Text] [Related]
16. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS
J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW
Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052
[TBL] [Abstract][Full Text] [Related]
19. Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.
Miller BJ; Wang D; Krahe R; Wright FA
Am J Hum Genet; 2003 Oct; 73(4):748-67. PubMed ID: 13680524
[TBL] [Abstract][Full Text] [Related]
20. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
